Literature DB >> 1600331

Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis.

D Basso1, C Fabris, M Plebani, G Del Favero, M Muraca, M T Vilei, M P Panozzo, T Meggiato, P Fogar, A Burlina.   

Abstract

This study was performed to investigate modifications in the serum bilirubin forms, hepatobiliary enzymes, and some glycoproteic substances in patients during the course of extrahepatic cholestasis (stage A) and following its clinical resolution (stage B). The series consisted of 16 patients: 11 had main bile duct stones; two, benign stenosis of the main bile duct; and three, main bile duct cancer. Cholestasis resolved spontaneously in one case, under endoscopy in two, and following surgery in 13. Five patients with liver cirrhosis and a picture of intrahepatic cholestasis following anesthesia were also investigated. Serum bilirubin forms were measured using van den Bergh's method and the alkaline methanolysis-HPLC procedure; the mono- and di-conjugated forms were considered together in the overall evaluation of the results. The hepatobiliary enzymes (ALP, GGT, and AST) were increased at stage A and significantly decreased at stage B. Similar patterns were observed in total (TB), unconjugated (UB), and conjugated bilirubin (CB) and in the percentage of CB out of TB (% CB). In the majority of patients, % CB at stage B was lower than at stage A, whereas in subjects with a high initial UB value, a different % CB pattern was observed. The direct bilirubin percentage (% DB), on the other hand, had a different pattern, and the variations between stages A and B were not significant. The pathophysiological bilirubin pattern was similar in patients with intrahepatic cholestasis. At stage A, in a number of patients the levels of glycoproteic substances (CA 19-9, TPA and ferritin) were raised, but at stage B they tended to decrease towards the normal range.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600331     DOI: 10.1007/bf00422939

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  20 in total

Review 1.  Analytic aspects and clinical interpretation of serum bilirubins.

Authors:  M Muraca; J Fevery; N Blanckaert
Journal:  Semin Liver Dis       Date:  1988-05       Impact factor: 6.115

2.  Serum tissue polypeptide antigen in pancreatic cancer and other gastrointestinal diseases.

Authors:  D Basso; C Fabris; A Piccoli; M Plebani; G Del Favero
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

3.  Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 cases.

Authors:  G Encabo; A Ruibal
Journal:  Bull Cancer       Date:  1986       Impact factor: 1.276

4.  A kinetic photometric method for serum gamma-glutamyl transpeptidase.

Authors:  G Szasz
Journal:  Clin Chem       Date:  1969-02       Impact factor: 8.327

Review 5.  Alkaline phosphatase and cholestasis.

Authors:  R W Wulkan; B Leijnse
Journal:  Ann Clin Biochem       Date:  1986-07       Impact factor: 2.057

6.  Enzyme changes and morphometric analysis of bile ducts in experimental bile duct obstruction.

Authors:  M M Kaplan; G C Kanel; J A Singer
Journal:  Clin Chim Acta       Date:  1979-12-03       Impact factor: 3.786

7.  IFCC methods for the measurement of catalytic concentrations of enzymes. part 3, IFCC. Method for alanine aminotransferase (l-alanine 2 -oxoglutarate aminotransferase, ec 2.6.1.2).

Authors: 
Journal:  Clin Chim Acta       Date:  1980-07-17       Impact factor: 3.786

8.  Combined determination of serum CA 19-9 and tissue polypeptide antigen: why no improvement in pancreatic cancer diagnosis?

Authors:  D Basso; C Fabris; G Del Favero; A Panucci; M Plebani; C Angonese; G Leandro; G Dodi; A Burlina; R Naccarato
Journal:  Oncology       Date:  1988       Impact factor: 2.935

9.  CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases.

Authors:  M Paganuzzi; M Onetto; P Marroni; D Barone; M Conio; H Aste; V Pugliese
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

10.  A reference method for measurement of alkaline phosphatase activity in human serum.

Authors:  N W Tietz; C A Burtis; P Duncan; K Ervin; C J Petitclerc; A D Rinker; D Shuey; E R Zygowicz
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

View more
  3 in total

1.  The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.

Authors:  Umashankar K Ballehaninna; Ronald S Chamberlain
Journal:  J Gastrointest Oncol       Date:  2012-06

2.  Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma.

Authors:  Marius Distler; Felix Rückert; Maximilian Hunger; Stephan Kersting; Christian Pilarsky; Hans-Detlev Saeger; Robert Grützmann
Journal:  BMC Surg       Date:  2013-04-22       Impact factor: 2.102

Review 3.  Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2014-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.